Pfizer
PFE
2,075 hedge funds and large institutions have $145B invested in Pfizer in 2017 Q1 according to their latest regulatory filings, with 115 funds opening new positions, 858 increasing their positions, 909 reducing their positions, and 77 closing their positions.
49% more first-time investments, than exits
New positions opened: 115 | Existing positions closed: 77
5% more funds holding in top 10
Funds holding in top 10: 172 → 180 (+8)
4% more capital invested
Capital invested by funds: $140B → $145B (+$5.17B)
1% more funds holding
Funds holding: 2,059 → 2,075 (+16)
0.24% more ownership
Funds ownership: 70.78% → 71.02% (+0.24%)
6% less repeat investments, than reductions
Existing positions increased: 858 | Existing positions reduced: 909
26% less call options, than puts
Call options by funds: $1.5B | Put options by funds: $2.01B
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
+$14.3B |
| 2 |
Massachusetts Financial Services
Boston,
Massachusetts
|
+$348M |
| 3 |
CWM
CIBC World Markets
New York
|
+$335M |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$242M |
| 5 |
Swiss National Bank
Zurich,
Switzerland
|
+$156M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AllianceBernstein
Nashville,
Tennessee
|
-$368M |
| 2 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$253M |
| 3 |
APG Asset Management
Amsterdam,
Netherlands
|
-$178M |
| 4 |
Capital World Investors
Los Angeles,
California
|
-$164M |
| 5 |
Lazard Asset Management
New York
|
-$158M |
PFE Hedge Fund Activity: Q1 2017 in Review
2,075 of the 4,034 institutional investors tracked by Wall St. Rank reported a position in Pfizer (PFE) for Q1 2017, worth a combined $145B — up 3.7% from $140B a quarter earlier.
Buyers outnumbered sellers: 115 funds opened new PFE positions and 77 closed out — a net gain of 38 holders — while 858 added to existing stakes and 909 trimmed.
The largest buyer was BlackRock, adding an estimated $14.3B. The largest seller was AllianceBernstein, cutting an estimated $368M.
- 2,075 institutional investors held Pfizer (PFE) as of Q1 2017, up from 2,059 in Q4 2016.
- Funds reported $145B of Pfizer stock for Q1 2017, up 3.7% quarter-over-quarter.
- 115 funds opened new Pfizer positions in Q1 2017 and 77 closed out, a net change of +38 holders.
- The largest Pfizer buyer in Q1 2017 was BlackRock, an estimated $14.3B added.
- The largest Pfizer seller in Q1 2017 was AllianceBernstein, an estimated $368M sold.
Based on aggregated 13F filings for Q1 2017.